---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-065334"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:49:32.525190+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology closes $9.0M public offering of 6.82M shares & warrants

## Summary
- Priced 6,818,182 units at $1.32 each, each consisting of 1 share + 1 warrant for 1 common share.
- Gross proceeds ~$9.0M; net proceeds ~$7.44M after placement agent fees and expenses.
- Warrants exercisable at $1.32/share, immediately exercisable, expire 5 years from issuance.
- Proceeds to support LYMPHIR commercialization, milestone/royalty payments, and working capital.
- Placement agent Maxim Group LLC; 45-day lock-up on new share issuance after closing.

## SEC filing metadata
- accession: 0001213900-25-065334
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/0001213900-25-065334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/ea0249292-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-065334
- JSON: https://secwatch.observer/filing/0001213900-25-065334.json
- Plain text: https://secwatch.observer/filing/0001213900-25-065334.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.